{"id":193009,"date":"2026-03-05T06:43:00","date_gmt":"2026-03-05T11:43:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/03\/05\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai\/"},"modified":"2026-03-05T07:50:11","modified_gmt":"2026-03-05T12:50:11","slug":"radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/03\/05\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai\/","title":{"rendered":"Radioligand Therapy Market Size Worth USD 36.47 Bn by 2035 AI"},"content":{"rendered":"<p><a href=\"https:\/\/www.openpr.com\/news\/4414051\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai\">Radioligand Therapy Market Size Worth USD 36.47 Bn by 2035 AI<\/a><\/p>\n<p><a href=\"https:\/\/www.openpr.com\/news\/4414051\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai\">https:\/\/www.openpr.com\/news\/4414051\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-03-05 06:43:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.openpr.com\">www.openpr.com<\/a><\/p>\n<ul>\n<li><strong>Market Size and Growth<\/strong>: The global radioligand therapy market is projected to grow significantly from USD 4.08 billion in 2026 to USD 36.47 billion by 2035, with a CAGR of 27.55%.<\/li>\n<li><strong>Key Drivers<\/strong>: Increased cancer cases, particularly prostate and neuroendocrine tumors, continuous advancements in radioligand technologies, and supportive regulatory frameworks drive the growth.<\/li>\n<li><strong>Regional Dominance<\/strong>: North America leads the market with 82% share in 2025 due to advanced healthcare infrastructure and high PET diagnostics adoption. Asia Pacific is expected to be the fastest-growing region.<\/li>\n<li><strong>Market Segments<\/strong>: By product, Lutetium Lu 177 Vipivotide Tetraxetan dominated in 2025. By indication, prostate cancer is the leading segment. By target, prostate-specific membrane antigen (PSMA) is dominant. <\/li>\n<li><strong>Leading Companies<\/strong>: Key players include Novartis AG, Bayer AG, and Eli Lilly and Company, among others, who are investing in manufacturing and therapy development.<\/li>\n<li><strong>Future Prospects<\/strong>: Anticipated growth in Asia-Pacific due to increasing cancer awareness and healthcare investments, and rapid adoption of AI and digital health technologies in cancer treatment.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Radioligand Therapy Market Size Worth USD 36.47 Bn by 2035 AI https:\/\/www.openpr.com\/news\/4414051\/radioligand-therapy-market-size-worth-usd-36-47-bn-by-2035-ai Publish Date: 2026-03-05&#8230;<\/p>\n","protected":false},"author":1,"featured_media":193010,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/cdn.open-pr.com\/L\/3\/L305254450_g.jpg","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-193009","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/193009"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=193009"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/193009\/revisions"}],"predecessor-version":[{"id":193011,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/193009\/revisions\/193011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/193010"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=193009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=193009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=193009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}